For multiple myeloma in its early stages if symptoms are present treatment is needed and treatment includes chemotherapy.
Multiple myeloma is a disease of malignant proliferation of plasma cells, characterized by a large number of clonal plasma cell proliferations in the bone marrow. For symptomatic multiple myeloma, even if it is only in the early stages, systematic treatment should be given, and treatment includes induction, consolidation and maintenance therapy. If there are no symptoms, treatment may be withheld for the time being.
Drugs for induction therapy include bortezomib, dexamethasone, lenalidomide, etc., which are used according to different conditions.
Autologous hematopoietic stem cell transplantation has better efficacy; consolidation therapy is mainly based on the original program for 2 to 4 courses of treatment; maintenance therapy can choose bortezomib, lenalidomide monotherapy or combined with dexamethasone and other drugs.
Multiple myeloma patients need to consult a doctor in time, standardized treatment under the guidance of the doctor, the drug should be used under the guidance of the doctor.